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Previous research has shown mild forms of the neurocognitive impairments seen in
schizophrenia among healthy individuals exhibiting high schizotypal traits. This study
aimed to explore associations between schizotypy and cognitive performance in an adult
community sample. Ninety-five females and 79 males completed the Oxford–Liverpool
Inventory of Feelings and Experiences (O-LIFE), which measures four separable aspects
of schizotypy: cognitive disorganization, unusual experiences, introvertive anhedonia, and
impulsive non-conformity. Subsequently, participants were administered a neurocognitive
battery incorporating measures of executive skills including inhibition, cognitive flexibility,
reasoning, and problem solving along with measures of attention and processing speed
and both verbal and spatial working memory. In line with predictions, the current study
found that higher scores on the subscales of unusual experiences, cognitive disorga-
nization, and impulsive non-conformity related to worse performance on a measure of
inhibition. Additionally, as introvertive anhedonia increased, both attention and processing
speed and reasoning and problem-solving performance became more impaired. In
conclusion, this study extends schizotypy literature by examining the subscales of the
O-LIFE, and enables inferences to be drawn in relation to cognitive impairment in
schizophrenia.
Keywords: schizotypy, schizotypal traits, psychosis proneness, cognition, executive functioning, attention,
inhibition, memory
Introduction
Schizophrenia generally a lifelong psychiatric illness associated with distressing mood, cognitive,
and functional symptoms (1). Cognitive impairment is a key component of schizophrenia and is
generally resistant to current treatment medications (2). In addition to an overall decrease in IQ,
a range of cognitive impairments have been found to be associated with the disorder, particularly in
the areas of “executive functioning,” an umbrella term referring to a range of functions that include
the capacity to plan, organize, attend to, monitor, and inhibit behaviors, as well as in the areas of
language and memory (3). Such cognitive deficits are likely to be premorbid, that is, they precede
the onset of the illness (2, 3). Additionally, they are usually stable or enduring throughout the course
of the illness and often remain during symptom remission (2, 3). Cognitive impairments hinder
day-to-day functioning and are one of the strongest predictors of clinical, social, and functional
outcomes, even more so than positive and negative symptomatology (2, 3). Cognitive functioning is
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also important to treatment decision-making and can be a good
predictor of treatment effects (2).
Mild forms of the cognitive deficits observed in schizophrenia
are also found in unaffected first-degree relatives and healthy
individuals exhibiting schizotypal traits (4, 5). This has led
recent studies to suggest several cognitive measures as poten-
tial “endophenotype candidates” or biological markers for the
illness (3–5). Schizotypy is a psychological construct involving
personality characteristics and perceptions, beliefs, and experi-
ences that are phenomenologically similar to, but less severe than
the symptoms of schizophrenia (6, 7). Consequently, schizotypy
represents a major focus area of research on schizophrenia and
the dimensional approach to it (8). By studying schizotypy in
the general population, predisposing and potentially protective
factors for schizophrenia can be explored, without the potential
confounds of symptoms, motivation deficits, illness chronicity,
and treatment medications (9). Recent literature has suggested
that schizotypy can be broken down into four factors, which reflect
those symptom factors seen in schizophrenia (10).
Positive schizotypy taps into perceptual aberrations, magical
thinking, unusual experiences, and hallucinations, and is thought
to resemble positive symptomatology in schizophrenia (7, 8).
Negative schizotypy encompasses introvertive anhedonia, in par-
ticular, a lack of social and physical enjoyment and an avoidance
of social connections, which is suggested to reflect negative symp-
tomatology (7, 8). Cognitive disorganization taps into deficits in
decision-making abilities, concentration, attention, language, and
thought disorder (7, 8). Lastly, asocial behavior taps into impul-
sive non-conformity, such as reckless, harmful, or disinhibited
behaviors (7).
Poorer neurocognitive performance similar to that seen in
schizophrenia, albeit in a milder form, has been identified in
individuals exhibiting high levels of schizotypy traits (11). For
example, inferior levels of attention and executive functioning
have been revealed: Cimino and Haywood (12) found healthy
individuals high in schizotypy traits, based on a mean of all
Oxford–Liverpool Inventory of Feelings and Experiences (O-
LIFE; a self-report inventory assessing schizotypy) factor scores, to
exhibit significantlymore errors and longer latencies on the Stroop
Color–Word Interference Test, in comparison with individuals
low in schizotypal traits. This finding is indicative of relative
impairments in inhibition and attentional switching or cognitive
flexibility (12). However, findings of cognitive disinhibition in
schizotypy have not always been consistent. For example, some
studies have found no significant associations between schizo-
typy factors and Stroop Color–Word Interference Test perfor-
mance (13, 14). Conversely, using theWisconsin Card Sorting Test
(WCST), both Gooding et al. (11) and Kim et al. (15) revealed
comparative deficits in cognitive flexibility in university students
exhibiting high levels of schizotypal traits. This was evidenced
by fewer categories achieved and increased preservative errors
compared with controls (11, 15).
Additionally, further evidence for poorer performance in atten-
tion and executive functioning has been identified by past
research. Using the O-LIFE in a university sample, Rawlings and
Goldberg (16) revealed a significant association between positive
schizotypy and decreased sustained attention, as evidenced by a
positive relationship between the cognitive disorganization fac-
tor of the O-LIFE and poorer performance on the Continuous
Performance Task. Chen et al. (9) had similar findings, however,
also found an association between negative schizotypy and poor
performance on the Continuous Performance Task.
Relative deficits in verbal and spatial working memory have
also been identified by previous research. For instance, using a
university sample, Matheson and Langdon (17) found that once
age was controlled for verbal working memory, as evidenced by
correct manipulations on the Letter–Number Sequencing Task,
was a significant predictor of cognitive, perceptual, and nega-
tive interpersonal schizotypal traits. Similar associations between
schizotypy and spatial working memory have also been revealed
by previous studies (18). However, findings between working
memory and schizotypy have not always been replicated, for
example, Lenzenweger and Gold (19) did not identify a signifi-
cant relationship between positive schizotypy and verbal working
memory (Letter–Number Sequencing Task).
Only a small number of studies have examined cognitive func-
tioning in relation to separate schizotypy factors. These studies
suggest that lowered performance in attention, executive func-
tioning, and sustained attention (using aContinuous Performance
Task) is related to higher scores on the cognitive disorganization
schizotypy factor as well as negative schizotypy (9, 16).
Taken together, these findings suggest that high schizotypy is
associated with reduced cognitive ability (albeit milder than that
seen in schizophrenia). However, this is a very broad finding and
more fine-grained analysis of the nature of this relationship is
required. As discussed, there are currently only a small number
of articles examining the schizotypy subtypes (9, 16). Further-
more, past schizotypy research has predominantly relied upon
adolescent or university educated samples who are unlikely to
be a good match to the schizophrenia population generally. By
using a sample of adults over the average age for schizophrenia
onset, it is assumed that the schizotypal traits exhibited by indi-
viduals are likely to lie within healthy limits and therefore are
not dormant symptoms of psychopathology (20). Additionally,
previous literature has identified first-degree relatives of patients
with schizophrenia to score significantly higher and with more
variation for both positive and negative schizotypy compared
with controls (21). Consequentially, by using extensive exclusion
criteria that restricts the presence of individuals with a current
psychiatric illness or with a family history of a schizophrenia
spectrum disorder or bipolar disorder, the dormant symptoms
of psychopathology are further controlled for and the sample is
therefore likely to be more homogenous in regards to schizotypal
traits. Lastly, due to primarily small sample sizes in previous
studies, the need for the exploration of the association between
schizotypy and cognition and a large sample is evident.
Based on shortcomings in the literature, the current study
aimed to explore the relationship between the four-schizotypy
factors defined in the O-LIFE and those areas of cognition, which
have previously been found to relate to schizotypy (inhibition,
cognitive flexibility, attention, processing speed, and reasoning
and problem solving) using traditional neurocognitive tasks. This
study will address previous limitations by (a) looking at the rela-
tionship between individual schizotypy factors of the O-LIFE and
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cognition, (b) using a large sample, (c) over the typical age for
schizophrenia onset, and (d) free fromgenetic liability and current
psychopathology.
Given previous findings of inhibitory deficits in schizophrenia
patients and high schizotypy samples, it was hypothesized that
higher scores on the unusual experiences and cognitive disorgani-
zation factors of the O-LIFE would relate to poorer inhibition and
cognitive flexibility, as measured by the Color–Word Interference
Test performance. Additionally, in line with previous schizotypy
literature, it was predicted that the introvertive anhedonia factor
of the O-LIFE would negatively associate with reduced attention
and processing speed, as measured by the Trail Making Test –
Part A. Furthermore, it was hypothesized that there would be
a negative association between the unusual experiences, intro-
vertive anhedonia and impulsive non-conformity factors, and
reasoning and problem-solving performance, as measured by a
Mazes task. Lastly, based on previous findings inworkingmemory
and schizotypy, a negative relationship was also expected between
both the unusual experiences and introvertive anhedonia factors,
and verbal and spatial working memory performance, as mea-
sured by the Letter–Number Sequencing and Spatial Span Tasks.
Furthermore, exploratory analyses of the four-schizotypy factors
and all neurocognitive variables will be conducted.
Materials and Methods
Participants
Potential participants voluntarily responded to advertising
through flyers at local community centers and the researcher’s
private social media pages. Following telephone screening, 175
healthy adults between 18 and 64 years of age (95 women and
79 men) met participation inclusion criteria. Participants were
excluded from the study if they had a current psychiatric illness;
history of or first-degree biological relative with schizophrenia or
schizoaffective disorder; current use of a psychotropic drug; or,
history of substance abuse or neurological illness. Demographic
information revealed that one included participant was adopted
(hence, knowledge of their biological relatives’ psychiatric
history was unknown), and one participant was color blind. The
participant whowas color blind was excluded from all color–word
interference tasks. All participants were financially reimbursed
for their time and travel costs. The Alfred Health Human Ethics
Committee and the Monash University Standing Committee
on Ethics in Research in Humans approved all experimental
procedures and informed written consent was obtained by all
participants in accordance with these ethical requirements.
Materials
Screening Interview
The Mini-International Neuropsychiatric Interview (M.I.N.I.), a
clinician-rated brief structured psychiatric interview compatible
with DSM-IV diagnostic criteria, was used to screen for the
presence of psychiatric conditions (22).
The Montgomery Äsberg Depression Rating Scale (MADRS), a
10-item clinician-rated scale, was used to assess the presence
and severity of depressive symptoms, relating to the previous
week (23). Items are scored on a six-point Likert scale (0–5) and
summed to calculate a total score ranging from0 to 50, with higher
scores indicating greater depression severity (24).
The Wechsler Test of Adult Reading (WTAR) included to pro-
vide an estimate of intellectual functioning and premorbid verbal
intelligence (25).
Schizotypy Assessment
The Oxford–Liverpool Inventory of Feelings and Experiences
(O-LIFE) is a self-report questionnaire designed to measure
psychosis-proneness, principally schizotypy in healthy individuals
(8). The questionnaire consists of four scales: unusual experi-
ences comprise 30-items and reflect positive symptomatology, for
example, “Do you believe in telepathy?” Cognitive disorganization
consists of 24-items and reflects cognitive deficits and thought
disorder, for example, “Is it hard for you tomake decisions?” Intro-
vertive anhedonia comprises 27-items and reflects negative symp-
tomatology, for example, “Do you prefer watching television or
going out with people?” Lastly, impulsive non-conformity reflects
a-social behavior and consists of 23-items, for example, “Do you
at times have an urge to do something harmful or shocking?”
Inhibition and Cognitive Flexibility Assessment
The Delis–Kaplan Executive Function System (D-KEFS),
Color–Word Interference Test, assesses inhibition and switching or
cognitive flexibility (25, 26). The test consists of four conditions,
each comprising 40-items: condition 1 requires respondents to
name patches of color. In the second condition, respondents
are required to read color names written in black ink. The third
condition requires respondents to name the dissonant ink color
that words are written in. In the fourth condition, respondents
are required to switch between naming the dissonant ink color
and reading the words. Each condition is timed and both self-
corrected and unknown errors are summed for each condition to
calculate a score for both raw time and total errors, ranging from
1 to 40, with higher scores indicating greater number of errors
(25, 26).
For this study, the four variables of interest were: Inhibition
V Color Naming raw time, which was a measure of inhibitory
latency, once baseline color naming was controlled for by sub-
tracting the raw seconds required for the first condition from
the third condition; Inhibition/Switching V Inhibition raw time
that was a score of cognitive flexibility or attentional switching,
after inhibition was controlled for by subtracting the seconds
score of the third condition from the fourth condition; Inhibi-
tion/Switching V Color Naming raw time, which was a measure
of inhibitory latency and cognitive flexibility, once color naming
was controlled for by subtracting the seconds required for the first
condition from the fourth condition; and Inhibition/Switching
V Word Reading raw time that was a measure of inhibitory
latency and cognitive flexibility, after baseline wording reading
was controlled for by subtracting the seconds taken for the second
condition from the fourth condition.
Attention and Processing Speed Assessment
The Halstead–Reitan Neuropsychological Test Battery (HRB), Trail
Making Test – Part A, was designed to measure attention and
processing speed (27). The task requires participants to connect 25
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numbers in ascending order that are randomly arranged on a page
within an assigned maximum time of 300 s (27). Prior to formal
task administration, participants first complete a sample exercise
containing eight numbers (27). Administration of the task takes
approximately 5min and the completion time in seconds for the
formal component is used as a total score with the number of
errors expressed also being recorded (27).
Reasoning and Problem Solving Assessment
The Neuropsychological Assessment Battery (NAB) – Mazes
assesses executive functioning, particularly planning and orga-
nization (28). The task requires participants to trace their way
through a series of seven mazes of increasing difficulty (28). The
time limit for each maze varies with the difficulty level and ranges
from 30 to 240 s (28). Mazes are scored based on completion and
response speed, with scores ranging from 0 to 26, with higher
scores indicating better performance (28).
Working Memory Assessment
The Wechsler Memory Scale – Third Edition (WMS-III) –
Letter–Number Sequencing assesses verbal working memory (29).
The task requires the researcher to read a series of numbers and
letters and the participant is required to recite the digits back to the
researcher, numbers first in ascending order followed by letters in
alphabetical order, with the lists increasing in difficulty (29). The
task consists of 24 trials and each correct recitation receives a score
of one, with individual scores summed to calculate a total score
ranging from 0 to 24, with higher scores indicating better working
memory performance (29).
The WMS-III – Spatial Span assesses spatial working memory
and consists of two conditions: forwards and backwards (29).
The first condition, forwards, consists of 16 trials and requires
the researcher to touch the blocks on the Spatial Span board in
an order in which the participants must repeat, with increasing
difficulty (29). The second condition, backwards, again consists
of 16 trials and participants are required to touch the blocks in the
reverse order to that of the researcher, with increasing difficulty
(29). Each correct trial obtains a score of 1, with individual scores
summed to calculate a total score for each condition, ranging
from 0 to 16 (29). Condition scores are then summed to calculate
an overall total score ranging from 0 to 32, with higher scores
indicating better working memory performance (29).
Procedure
Following a basic telephone assessment of eligibility, participants
completed a demographic questionnaire and the O-LIFE. Sub-
sequently, a brief screening interview took place, consisting of
the M.I.N.I. screen and the MADRS. The neurocognitive battery
was then administered successively, with counterbalancing used
to reduce order effects and fatigue.
Results
Data Analysis
All raw scores were processed using PASW Version 18 (SPSS
Ltd.) to produce the summary data. Although statistical analyses
were based on previous literature, due to multiple comparisons,
the alpha level for all statistical analyses was set at 0.01, unless
otherwise stated.
Prior to analyses, assumption testing was conducted to assess
the suitability of the data for a correlation analysis. Following
inspection of the Frequency Table, it was found that a small per-
centage of data was missing from each of the variables (<5% per
variable); caseswere therefore excludedpairwise for all further sta-
tistical analyses. Kolmogorov–Smirnov normality tests revealed
that the data violated this assumption and consequently non-
parametric tests (Spearman’s rho) were used for all additional
analyses.
Demographics
There were no significant associations between age, years of
education, verbal intelligence and depression, as evidenced by the
WTAR, MADRS depression scores (see Table 1 for descriptive
statistics of the demographic variables; see the Supplementary
Material for results of the Spearman’s Rho analyses for
neurocognitive variables by schizotypy factors) schizotypy factors
scores and the neurocognitive variables (p= 0.017–0.908). Conse-
quently, these variables were not controlled for in further analyses.
Descriptive Statistics and Schizotypy
Factor Scores
The descriptive statistics for all neurocognitive variables are pre-
sented in Table 2. This table reveals the highest schizotypy factor
scores to be for cognitive disorganization and impulsive non-
conformity.
To further explore relationships between schizotypy factors and
neurocognitive variables, a two-tailed Spearman’s rho correlation
analysis was conducted and results are presented below.
Inhibition and Cognitive Flexibility
In terms of assessing inhibition, the analysis revealed a significant
positive association between unusual experiences and inhibition
versus color naming raw time [rs(164)= 0.333, p= 0.000], inhi-
bition/switching versus color naming raw time [rs(166)= 0.347,
p= 0.000], and inhibition/switching versus word reading raw
time [rs(166)= 0.345, p= 0.000], accounting for 11.08, 12.04, and
11.90% of shared variance, respectively.
The Spearman’s rho analysis also revealed a significant
positive relationship between cognitive disorganization and
inhibition versus color naming raw time [rs(164)= 0.21,
p= 0.007], inhibition/switching versus color naming raw time
[rs(166)= 0.24, p= 0.002], and inhibition/switching versus word
reading raw time [rs(166)= 0.258, p= 0.001], accounting for 4.41,
5.76, and 6.66% of shared variance, respectively. The analysis
TABLE 1 | Descriptive statistics for demographic variables.
Mean SD Min Max
Age 34:05 13:66 18 64
Years of education 16:27 2:83 9 27
WTAR scaled score 112:30 8:11 83 129
MADRS 1:79 3:01 0 26
WTAR, Wechsler Test of Adult Reading; MADRS, Montgomery Äsberg Depression Rating
Scale.
Frontiers in Psychiatry | www.frontiersin.org June 2015 | Volume 6 | Article 794
Louise et al. Schizotypy and cognition
TABLE 2 | Descriptive statistics for all neurocognitive variables and schizotypy factors.
N Missing N% Mean SD Range TR
O-LIFE
Unusual experiences 171 2:3 4:98 4:86 0–25 0–30
Cognitive disorganization 171 2:3 7:22 5:24 0–20 0–24
Introvertive anhedonia 170 2:9 4:16 3:63 0–20 0–27
Impulsive non-conformity 172 1:7 7:20 4:13 0–19 0–23
D-KEFS Inhibition V Color Naming 168 4 10:54 8:21  5 to 37 –
D-KEFS Inhibition/Switching V Inhibition 170 2:9 5:88 7:47  12.4 to 28.20 –
D-KEFS Inhibition/Switching V Color Naming 170 2:9 12:81 11:60  4 to 49.6 –
D-KEFS Inhibition/Switching V Word Reading 170 2:9 14:89 14:69  4 to 57 –
Trail Making Test – Part A 173 1:1 25:56 8:91 11–68 300 s
Mazes 172 1:7 10:61 5:65 3–26 0–26
Letter–number sequencing 173 1:1 16:79 2:59 10–24 0–24
Spatial span backwards 175 0 8:95 1:80 2–14 0–16
Range, observed range of scores; TR, theoretical range of scores; O-LIFE, Oxford–Liverpool Inventory of Feelings and Experiences; D-KEFS, Delis–Kaplan Executive Function System.
D-KEFS variables are measured in raw seconds.
also identified a non-significant positive trend between cognitive
disorganization and inhibition/switching versus inhibition
[rs(166)= 0.189, p= 0.014].
Additionally, the exploratory analysis showed a significant posi-
tive association between impulsive non-conformity and inhibition
versus color naming raw time [rs(165)= 0.450, p= 0.000], inhibi-
tion/switching versus color naming [rs(167)= 0.453, p= 0.000],
and inhibition/switching versus word reading [rs(167)= 0.433,
p= 0.000], which accounted for 20.25, 20.52, and 18.75%of shared
variance, respectively. Furthermore, a non-significant positive
trend was identified between impulsive non-conformity and inhi-
bition/switching versus inhibition [rs(167)= 0.168, p= 0.030].
Attention and Processing Speed
In regards to attention and processing speed, the Spearman’s rho
analysis showed a significant positive relationship between intro-
vertive anhedonia and Trail Making Test – Part A [rs(168)= 0.26,
p= 0.001], accounting for a small amount of shared variance
(6.76%).
Reasoning and Problem Solving
In respect to planning and organization, a significant neg-
ative relationship between introvertive anhedonia and mazes
raw score [rs(168)= 0.212, p= 0.006] was revealed by analysis
that accounted for a small amount of shared variance (4.49%).
Conversely, analysis also showed a significant positive associ-
ation between impulsive non-conformity and mazes raw score
[rs(170)= 0.299, p= 0.000], accounting for a small percentage of
shared variance (8.94%).
Working Memory
In relation to working memory measures, the analysis revealed
a non-significant positive trend between unusual experiences
and letter–number sequencing raw score [rs(169)= 0.143,
p= 0.064]. Moreover, exploratory analysis identified a positive
non-significant trend between cognitive disorganization
[rs(175)= 0.152, p= 0.051], impulsive non-conformity
[rs(175)= 0.161, p= 0.038], and spatial span backwards raw
score, which accounted for a small percentage of shared variance,
2.31 and 2.59%, respectively.
Discussion
The current study aimed to explore associations between schizo-
typy factors and cognition in an adult community sample.
The key findings from this study were significant positive
associations between unusual experiences, cognitive disorgani-
zation, and impulsive non-conformity and inhibitory latency
and cognitive flexibility on the Color–Word Interference Test,
once baseline color naming and word reading were controlled.
Additionally, findings revealed a significant positive associa-
tion between introvertive anhedonia and attention and process-
ing speed on the Trail Making Test – Part A. Lastly, results
showed a significant negative association between introvertive
anhedonia and reasoning and problem solving on the mazes
task and a significant positive relationship between impulsive
non-conformity and reasoning and problem solving on the
mazes task.
Our findings of associations between positive, cognitive, and
asocial schizotypal traits and impairments in inhibition and
cognitive flexibility or attentional switching (Color–Word Inter-
ference Test) are in line with past studies that have found
high schizotypes to display greater inhibitory latency and less
accurate responses compared with low schizotypes on all inhi-
bition and switching conditions of the Color–Word Interfer-
ence Test (12). These findings are also in line with recent
schizophrenia research, which has revealed inhibitory deficits
using the Color–Word Interference Test (30). However, while
the schizophrenia literature frequently reports a relationship
with inhibitory deficits, negative symptoms are often related
to inhibition, rather than positive symptoms (30). Albeit non-
significant, results identified positive trends toward relation-
ships between cognitive disorganization and impulsive non-
conformity and cognitive flexibility, once baseline inhibition was
controlled.
Furthermore, our results of a relationship between negative
schizotypal traits and reduced attention and processing speed are
consistent with past research reporting an association between
negative and cognitive schizotypal traits and poorer sustained
attention, as measured by the Continuous Performance Task, in
a community sample (9). Similarly, these findings are in line
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with previous schizophrenia research that found patients to
score significantly lower on the Continuous Performance Task
compared with controls (31).
Additionally, the current study found a significant negative
association between introvertive anhedonia and completion time
on a mazes task, suggesting that higher levels of negative schizo-
typy are related to poorer reasoning and problem-solving perfor-
mance. This is consistent with previous schizophrenia research
that found patients to demonstrate significant impairment on a
mazes task in comparison with controls (32). In contrast and
somewhat counter intuitively, current results also revealed a sig-
nificant positive association between impulsive non-conformity
and superior reasoning and problem-solving performance. One
potential explanation for this inconsistent finding is that faster
task commencement times associated with impulsivity may have
aided in participants’ increased mazes scores. In comparison
with other mazes tasks, the current task did not penalize partic-
ipant’s performance when they entered into a “blind alley.” For
instance, the Porteous Maze task records a trial as unsuccessful
if such behavior takes place (25). The current participants are
likely to have benefited from the added speed associated with
impulsivity without being punished for this commonly committed
error.
Limitations
A couple of noteworthy methodological shortcomings exist in the
current study. For instance, schizotypy factor scores identified in
this study were below current normative scores for the O-LIFE
inventory (8). Due to the restricted range of schizotypy scores
in the current sample, it is possible that relationships between
schizotypy factor scores and neurocognitive variables may have
been revealed using a sample with a larger spread of schizotypy
scores.
In addition, previous literature has suggested the use of illicit
drugs to impact both schizotypy scores and cognitive perfor-
mance, particularly inhibition (33). Although the current study
did exclude participants if theymet criteria for a current substance
disorder based on theM.I.N.I. screen, it did not, however, evaluate
or control the current use of illicit drugs that were not severe
enough to meet this criteria. As current use of cannabis can result
in healthy individuals to mimic inhibitory impairments seen in
schizophrenia, controlling the use of such substances may have
been beneficial.
Conclusion
In conclusion, the current study was one of the first in schizotypy
literature to tease apart the relationships between factor scores
and cognition in an adult community sample that accounted
for psychiatric illness and family history. This allowed for the
exploration of both cognitive functioning and potential compen-
satory mechanisms in individuals who have passed the peak onset
times for developing schizophrenia. Findings from the current
study further extend a limited body of schizotypy literature that
enables inferences to be drawn in relation to the cognitive deficits
seen in schizophrenia, without the potential confounds of illness
chronicity and treatment medications. A better understanding of
cognitive performance in schizophrenia is essential due to the vast
experience of cognitive deficits and resistance to current treatment
medications. Consequently, this research has potential practical
implications for aiding in the establishment of treatments, to
be used in conjunction with antipsychotic medication, for the
cognitive symptoms of schizophrenia.
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